Morus Inc. (CEO: Ryo Sato; Headquarters: Chiyoda-ku, Tokyo; “Morus”), whose vision is “Crafting through Tradition, Thriving with Nutrition.,” has moved into the Okinawa Health Biotechnology Research and Development Center in Uruma City, Okinawa Prefecture, and opened its first research base equipped with its own in-house laboratory. At the new base, Morus will research the functional properties of MorSilk®, its silkworm-derived ingredient, and build a framework for mass production in Japan.
Bringing the value of MorSilk® to society requires two things: confirming the scientific evidence step by step through research, and building a production system that can supply it consistently while maintaining quality.
The purpose of moving into the Okinawa Health Biotechnology Research and Development Center, a facility that supports the research and development of bioscience companies, is to advance both research and production in one place.
| Item | Details |
| Facility | Okinawa Health Biotechnology Research and Development Center (OHBIC) |
| Address | 12-75 Suzaki, Uruma City, Okinawa 904-2234, Japan |
| Move-in date | October 1, 2026 |
Dr. Seiji Aoyagi (PhD in Nutrition) has been appointed Center Director and Head of Functional Research, and will advance further research into the functional properties of MorSilk®.
Ayu Fujii, Director and Chief Innovation Officer, will lead manufacturing and processing research, covering processing methods for the raw material and product development. In parallel, Morus will develop its own domestic mass-production system, verifying each step from silkworm rearing to processing, with the aim of establishing stable production in Japan.
Through biotechnology and nutrition science, Morus will continue to explore the functional properties of the silkworm and work to help address health challenges around the world.
